Eric Raymond
Overview
Explore the profile of Eric Raymond including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
184
Citations
7398
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hammel P, Smith D, Afchain P, Dominguez-Tinajero S, Seitz J, Lievre A, et al.
Ther Adv Med Oncol
. 2024 Nov;
16:17588359241290140.
PMID: 39563716
Background: Sunitinib, a multitarget tyrosine kinase inhibitor, showed encouraging antitumor activity and manageable toxicity in patients with advanced midgut neuroendocrine tumors (NETs) in earlier results from phase I and II...
2.
Lazar V, Raymond E, Magidi S, Bresson C, Wunder F, Berindan-Neagoe I, et al.
Ther Adv Med Oncol
. 2024 Oct;
16:17588359241289200.
PMID: 39429467
Background: Dysregulated pathways in cancer may be hub addicted. Identifying these dysregulated networks for targeting might lead to novel therapeutic options. Objective: Considering the hypothesis that central hubs are associated...
3.
Hernando J, Roca-Herrera M, Garcia-Alvarez A, Raymond E, Ruszniewski P, Kulke M, et al.
Eur J Cancer
. 2024 Apr;
203:114061.
PMID: 38609739
No abstract available.
4.
Mostaghat I, Couzigou C, Pilmis B, Castreau N, Raymond E, Maixant A, et al.
Ann Biol Clin (Paris)
. 2024 Feb;
81(6):640-644.
PMID: 38391168
Burkholderia pseudomallei is a Gram-negative saprophytic bacillus that causes melioidosis. The infection is endemic in South-East of Asia and Northern Australia. B. pseudomallei has been designated as bioterrorism agent and...
5.
Iseas S, Mariano G, Gros L, Baba-Hamed N, de Parades V, Adam J, et al.
Mol Diagn Ther
. 2024 Jan;
28(2):201-214.
PMID: 38267771
Anal squamous cell carcinoma (ASCC) is a rare gastrointestinal malignancy associated with high-risk human papillomavirus (HPV) and is currently one of the fastest-growing causes of cancer incidence and mortality in...
6.
Bestion E, Rachid M, Tijeras-Raballand A, Roth G, Decaens T, Ansaldi C, et al.
Target Oncol
. 2023 Dec;
19(1):95-106.
PMID: 38133710
Background: Palmitoyl-protein thioesterase-1 (PPT1) is a clinical stage druggable target for inhibiting autophagy in cancer. Objective: We aimed to determine the cellular and molecular activity of targeting PPT1 using ezurpimtrostat,...
7.
Plisson M, Moll A, Sarrazin V, Charles D, Antoine T, Ionescu R, et al.
J Insur Med
. 2023 Sep;
50(1):36-48.
PMID: 37725502
Introduction: -Due to early detection and improved therapies, the prevalence of long-term breast cancer survivors is increasing. This has increased the need for more inclusive underwriting in individuals with a...
8.
Vienot A, Jacquin M, Rebucci-Peixoto M, Pureur D, Ghiringhelli F, Assenat E, et al.
BMC Cancer
. 2023 Jul;
23(1):710.
PMID: 37516867
Background: Several cancer immunotherapies that target the PD-L1/PD-1 pathway show promising clinical activity in patients with hepatocellular carcinoma (HCC). However, the standard of care in first-line treatment with atezolizumab (anti-PD-L1...
9.
Bestion E, Raymond E, Mezouar S, Halfon P
Cells
. 2023 Jul;
12(13).
PMID: 37443736
Autophagy is a highly conserved and natural degradation process that helps maintain cell homeostasis through the elimination of old, worn, and defective cellular components, ensuring proper cell energy intake. The...
10.
Hernando J, Roca-Herrera M, Garcia-Alvarez A, Raymond E, Ruszniewski P, Kulke M, et al.
Eur J Cancer
. 2023 May;
188:39-48.
PMID: 37196483
Purpose: There is an increasing interest in the role of sex and gender in cancer patients. The impact of sex differences in oncological systemic therapies is still unknown, and there...